SCHEMBL1669878

SCHEMBL1669878

NC(=O)C(Br)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL380421 0.78
SCHEMBL16401948 0.78 CYP2C19 (0.44)
SCHEMBL3911470 0.75
SCHEMBL1771381 0.75
SCHEMBL10639212 0.75
SCHEMBL6533057 0.75
SCHEMBL5040518 0.75
SCHEMBL310693 0.75
Ammonia Solution, Strong SCHEMBL9801972 0.75
SCHEMBL4421528 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115246797-B Azacrown ether compound, and preparation method and application thereof 中国科学院上海高等研究院 2023-07-21 CN claimed
CN-111380981-A Detection method of bromoacetamide 同济大学 2020-07-07 CN claimed
JP-7080470-A None JP disclosed
WO-2026102493-A1 METHODS OF CONTROLLING ANTI-METHANOGENIC HALOMETHANE PRODUCTION FutureFeed Pty Ltd (AU) 2026-05-21 WO disclosed
WO-2025262036-A1 METHOD OF MANUFACTURING A PHARMACEUTICAL COMPOSITION RNASSIST LTD (GB) 2025-12-26 WO disclosed
US-20250288573-A1 DIMERIC IMMUNO-MODULATORY COMPOUNDS AGAINST CEREBLON-BASED MECHANISMS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. 2025-09-18 US disclosed
US-20250283882-A1 HIGH SENSITIVITY DNA LINKED IMMUNOSORBENT SIGNAL AMPLIFICATION ASSAY (DLISA) FOR DETECTION OF INFECTIOUS SARS-COV-2 VIRUS AND VARIANTS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2025-09-11 US disclosed
US-20250222126-A1 NANOSCALE DNA-PEPTIDE HYBRID MOLECULES FOR MULTIVALENT PROTEIN BINDING UNIV ARIZONA STATE (US) 2025-07-10 US disclosed
US-12233054-B2 Dimeric immuno-modulatory compounds against cereblon-based mechanisms H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2025-02-25 US disclosed
WO-2025010326-A2 DIMERIC IMMUNO-MODULATORY COMPOUNDS AGAINST CEREBLON-BASED MECHANISMS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2025-01-09 WO disclosed
US-20240408194-A1 DNA ORIGAMI SUBUNIT VACCINE FOR PREVENTION OF SARS-CoV-2 VARIANT INFECTION NATIONAL INSTITUTES OF HEALTH 2024-12-12 US disclosed
EP-0722442-A1 POLYAZACYCLOALKANES AS DICHELANTS NYCOMED SALUTAR, INC. (US) 1996-07-24 EP disclosed
WO-1995009848-A2 POLYAZACYCLOALKANES AS DICHELANTS NYCOMED SALUTAR, INC. (US) 1995-04-13 WO disclosed
JP-H0780470-A WATER TREATMENT AGENT FOR STRERILIZATION MITSUBISHI GAS CHEM CO INC 1995-03-28 JP disclosed
US-4792628-A ANTIOXIDANTS, ANTIINFLAMMATORY AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1988-12-20 US disclosed
EP-0065724-B1 DIHALOGEN ACETAMIDES, PROCESS FOR THEIR PREPARATION AND HERBICIDES CONTAINING ACETANILIDES AS HERBICIDES AND DIHALOGEN ACETAMIDES AS ANTIDOTES BASF Aktiengesellschaft (DE) 1984-08-08 EP disclosed
EP-0065724-A1 Dihalogen acetamides, process for their preparation and herbicides containing acetanilides as herbicides and dihalogen acetamides as antidotes BASF Aktiengesellschaft (DE) 1982-12-01 EP disclosed
US-4343885-A PHOTORESISTS DYNACHEM CORPORATION (US) 1982-08-10 US disclosed
US-RE29826-E HALOCYANOACETAMIDE; WATER TREATMENT KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 1978-11-07 US disclosed
US-4022605-A HALOCYANOACETAMIDE KUMIAI CHEMICAL INDUSTRY CO., LTD. (JA) 1977-05-10 US disclosed